Deciphering albumin-directed drug delivery by imaging

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology
• Medical Imaging

Background:

• Albumin, the most abundant plasma protein, has a long half-life and is widely used in diagnostics and therapies.
• Many drugs bind albumin, but factors governing albumin-based transport and its impact on cancer pharmacology are not fully understood.
• Understanding albumin's role is crucial for advancing drug development and personalized medicine.

Purpose of the Study:

• To investigate the rate-limiting factors in albumin-based drug transport, especially in advanced solid cancers.
• To explore the impact of various biological mechanisms on albumin deposition and drug pharmacology.
• To highlight the utility of albumin-based imaging in understanding disease mechanisms and guiding treatment strategies.

Main Methods:

• Utilizing advanced imaging techniques to quantify albumin deposition at molecular and single-cell levels.
• Analyzing the influence of phagocytic immune cell signaling, FcRn-mediated recycling, and macropinocytosis.
• Employing albumin-binding probes for macroscopic imaging to assess vessel structure and permeability.

Main Results:

• Imaging reveals the intricate interplay of biological mechanisms affecting spatial albumin distribution.
• Albumin-binding probes provide insights into vascular characteristics and facilitate targeted molecular imaging.
• Data from patients and animal models demonstrate the feasibility of albumin-based imaging strategies.

Conclusions:

• Albumin-based imaging is a powerful tool for elucidating drug transport mechanisms in cancer.
• This approach aids in understanding spatial albumin deposition and its pharmacological consequences.
• Albumin imaging offers a promising strategy for drug development and personalized cancer therapy.